Abstract:BackgroundDuchenne Muscular Dystrophy (DMD) is the most common muscle disease in children, and there are no effective therapies for DMD or Becker Muscular Dystrophy (BMD). Currently, targeted gene therapy treatments have emerged. As a result, genetic diagnosis is the basis of treatment. In addition, genetic and prenatal diagnosis significantly reduces their incidence rates. This study combines the application of multiplex ligation-dependent probe amplification technology (MLPA) and "next-generation" sequencing technology (NGS) as the most economical and efficient method of diagnosis. Therefore, in the diagnosis of DMD/BMD, patients' MLPA data are first used to detect DMD gene deletions or duplications, and NGS and Sanger sequencing are then applied to exclude MLPA-negative samples. Meanwhile, polymerase chain reaction (PCR) is used to detect single exon deletions to exclude false-positives in MLPA caused by point mutations.MethodsIn this study, we recruited 1051 proband families of DMD from 2016 to 2018 and had access to information that could identify individual participants during or after data collection. Patients who were diagnosed with DMD were first tested by MLPA. MLPA results with single exon deletions were validated with PCR amplification and Sanger sequencing. The negative results of MLPA were further analysed with NGS and validated by Sanger sequencing. For novel missense mutations, phenotype-genotype correlations were analysed using PolyPhen2 and mutation taster. All methods were performed in accordance with the relevant guidelines and regulations.ResultsDMD mutations were identified in 1029 families (97.91%, 1029/1051). Large deletions, duplications, and small mutations accounted for 70.41% (740/1051), 8.28% (87/1051), and 19.12% (201/1051) of all cases, respectively. There were 205 small mutation types, 53 of which were novel. The rate of de novo mutations was 39.45% (187/474) and was higher in large duplications (49.53%, 157/317). Among 68 asymptomatic patients (< 3 years old) with unexplained persistent hyperCKaemia upon conventional physical examination, 63 were diagnosed as DMD/BMD according to genetic diagnosis.ConclusionOur results expand the spectrum of DMD mutations, which could contribute to the treatment of DMD/BMD and provide an effective diagnosis method. Thus, the combination of MLPA, NGS and Sanger sequencing is of great significance for family analysis, gene diagnosis and gene therapy.

The cryptic complex rearrangements involving the DMD gene: etiologic clues about phenotypical differences revealed by optical genome mapping

Novel Noncontiguous Duplications Identified with a Comprehensive Mutation Analysis in the DMD Gene by DMD Gene-Targeted Sequencing.

Detection of Cryptic Balanced Chromosomal Rearrangements Using High-Resolution Optical Genome Mapping

Genetic Identification of Pathogenic Variations of the DMD Gene: a Retrospective Study from 10,481 Neonatal Patients Based on Next-Generation Sequencing Data

Comprehensive Genetic Diagnosis of Patients with Duchenne/Becker Muscular Dystrophy (DMD/BMD) and Pathogenicity Analysis of Splice Site Variants in the DMD Gene

Research Progress on Disease Models and Gene Therapy of Duchenne Muscular Dystrophy

Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients.

Genotype–phenotype Correlation in Becker Muscular Dystrophy in Chinese Patients

Cryptic Exon Activation Caused by a Novel Deep-Intronic Splice-Altering Variant in Becker Muscular Dystrophy.

Targeted Next-Generation Sequencing As a Comprehensive Test for Patients with and Female Carriers of DMD/BMD: a Multi-Population Diagnostic Study

Comprehensive analysis of genomic complexity in the 5' end coding region of the DMD gene in patients of exons 1–2 duplications based on long-read sequencing

Clinical, Molecular Pathological and Genetic Analysis of a Chinese Family with Dystrophinopathy

DMD mutations in pediatric patients with phenotypes of Duchenne/Becker muscular dystrophy

A Resolved Discrepancy Between Multiplex PCR and Multiplex Ligation‐dependent Probe Amplification by Targeted Next‐generation Sequencing Discloses a Novel Partial Exonic Deletion in the Duchenne Muscular Dystrophy Gene

Genetic analysis of 1051 Chinese families with Duchenne/Becker Muscular Dystrophy

Study on Duchenne muscular dystrophy gene mutation and prenatal diagnosis]

Structural Analysis of DMD Gene and Its Clinical Application in Chinese.I.Bgl II Exon-Containing Fragment, RFLP and Carrier Detection

DMD Mutations in 576 Dystrophinopathy Families: A Step Forward in Genotype-Phenotype Correlations

Three novel splicing mutations at 5' terminal of DMD gene corresponding to different phenotypes

Novel Mutation Leading to Splice Donor Loss in a Conserved Site Ofdmdgene Causes Duchenne Muscular Dystrophy with Cryptorchidism

Analysis of RFLPs and DNA Deletions in the Chinese Duchenne Muscular Dystrophy Gene.